About this trial
Umbilical hernias can be found in over a quarter of the population and comprise of 15% of hernia repairs performed in Canada. While mesh repair is commonly used for larger hernias, smaller hernia defects are often closed with sutures alone. While non-absorbable sutures may have greater tensile strength, the use of absorbable sutures has been found to reduce the risk for wound infection and improve healing. The objective of this multi-centre, nationwide randomized controlled study is to determine whether there is a difference in hernia recurrence when the repair is completed with absorbable polydioxanone suture versus permanent polypropylene suture. The study will also explore post-operative complications and quality of life. Recruitment will take place over 5 years with follow-up at the 30-day, 12-month and 24-month mark following surgery. The results of this trial will be directly applicable to national and international hernia guidelines and will impact the care of thousands of patients.
Eligibility criteria
Qualifiers
Elective surgery for primary umbilical hernia with a defect ≤ 2 cm measured clinically or radiographically
Age 19 years or older
Patient able to give oral and written informed consent
Disqualifiers
Umbilical hernia defect > 2 cm measured clinically, radiologically, or intraoperatively with ruler
Multiple defects
Incisional hernia: prior hernia in area of operation
Recurrent umbilical hernia
Trial design
Treatments tested in this trial
- Permanent Suture
- Absorbable
Treatment groups
Sponsors and collaborators
University of British Columbia
Lead sponsor
North York General Hospital
Collaborator
Royal Victoria Hospital Of Barrie
Collaborator
London Health Sciences Centre
Collaborator
University of Alberta
Collaborator